is wegovy a glp-1 drug weight loss drugs may be misused by patients with eating disorders: Study How GLP-1 medications are transforming

42) In SUSTAIN-6, patients treated with semaglutide had a lower risk of developing or worsening nephropathy, but a higher risk of complications from diabetic retinopathy than those receiving placebo (40)

J Obes Weight Loss Medicat

doi: 10.1007/s00125-012-2592-3 115 LenerM

[31] performed preoperative gastric ultrasonography on 124 patients undergoing elective surgery under general anesthesia and found that those receiving once-weekly GLP-1 RAs (including semaglutide, dulaglutide, and tirzepatide) had a 30.5% higher incidence of increased gastric residual volume compared with the control group.The effect of GLP-1 RAs on delaying gastric emptying varies according to the specific agent and duration of use

Shuster, L

Effectiveness of shared medical appointments targeting the triple aim among patients with overweight, obesity, or diabetes